Anders Kronström, Chief Executive Officer

Has over 20 years of experience from senior positions in the pharmaceutical industry, including Head of Business Development at AstraZeneca R&D and Chief Techincal Officer at Infant Bacterial Therapeutics. Hold a MSc degree in Chemistry from the Royal Institute of Technology and a MBA from Warwick Business School.